Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-13
2006-06-13
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S277000, C514S345000, C514S351000, C514S352000, C514S357000, C546S257000, C546S258000, C546S259000, C546S290000, C546S304000
Reexamination Certificate
active
07060715
ABSTRACT:
The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I.The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 5284955 (1994-02-01), Strong
patent: 5438033 (1995-08-01), Drumm et al.
patent: 5480568 (1996-01-01), Pawloski et al.
patent: 5593994 (1997-01-01), Batt et al.
patent: 5686470 (1997-11-01), Weier et al.
patent: 5861419 (1999-01-01), Dube et al.
patent: 5916905 (1999-06-01), Weier et al.
patent: 5932586 (1999-08-01), Batt et al.
patent: 6001843 (1999-12-01), Dube et al.
patent: 6004950 (1999-12-01), Friesen et al.
patent: 6040319 (2000-03-01), Corley et al.
patent: 6040450 (2000-03-01), Davies et al.
patent: 6071936 (2000-06-01), Dube et al.
patent: 6127545 (2000-10-01), Pye et al.
patent: 6130334 (2000-10-01), Pye et al.
patent: 6204387 (2001-03-01), Davies et al.
patent: 6252116 (2001-06-01), Corley et al.
patent: 6596736 (2003-07-01), Dube et al.
patent: 6812346 (2004-11-01), Dube et al.
patent: 0 594 993 (1994-05-01), None
patent: WO 96/10012 (1996-04-01), None
patent: WO 96 16934 (1996-06-01), None
patent: WO 96 24584 (1996-08-01), None
P. Rocca, F. Marsais, Tetrahedron, vol. 49, No. 16, pp. 3325-3342, 1993.
Dube Daniel
Fortin Rejean
Friesen Richard
Gauthier Jacques Yves
Wang Zhaoyin
Merck Frosst Canada Ltd.
Rose David L.
Seaman D. Margaret
Yuro Raynard
LandOfFree
Substituted pyridines as selective cyclooxygenase-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyridines as selective cyclooxygenase-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyridines as selective cyclooxygenase-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3660180